Corient Private Wealth’s Lifecore Biomedical LFCR Stock Holding History
Bought
Maintained
Sold
Other funds holding LFCR
Corient Private Wealth's LFCR Position: Q3 2026 in Review
Corient Private Wealth opened a new position in Lifecore Biomedical (LFCR) in Q3 2026: 78,488 shares worth $516K. The stake represents ﹤0.01% of the portfolio and ranks #2441 among its holdings.
105 funds tracked by Wall St. Rank hold LFCR as of Q3 2026.
- Corient Private Wealth held 78,488 shares of Lifecore Biomedical worth $516K as of Q3 2026.
- Lifecore Biomedical was a new Corient Private Wealth position in Q3 2026.
- Lifecore Biomedical made up ﹤0.01% of Corient Private Wealth's portfolio in Q3 2026, its #2441 holding.
- 105 funds tracked by Wall St. Rank held Lifecore Biomedical as of Q3 2026.
Based on Corient Private Wealth's 13F filing for Q3 2026, filed 16 Nov 2026.